Summit on Advanced Therapeutics - (Joseph A. Oddis Ethics Colloquium) Advanced Therapeutics: Navigating Patient-Specific Variables to Optimize Outcomes
There is no CE associated with this activity. Release Date:June 08, 2025 Expiration Date: June 08, 2028 Activity Fee: Free for Members
This session was part of ASHP’s Summit on Advanced Therapeutics at Pharmacy Futures 2025. There is no CE associated with this activity.
Activity Overview
This activity willdiscuss howadvanced therapeutics offer remarkable potential to improve patient outcomes.Attendees will gain practical insights into interpreting clinical evidence to inform treatment decisions while addressing the ethical challenges that arise from social determinants of health.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
is activity is intended to meet the professional development needs of Certified Pharmacy Executive Leaders.
After completing this activity, the learner should be able to
Describe key patient-specific factors guiding selection and eligibility for the delivery of advanced therapeutics.
Assess clinical data and biomarkers to make informed decisions about patient eligibility for advanced therapeutics.
Identify ethical challenges that arise from social determinants of health that impact advanced therapeutic availability and patient access to care.
Introduction and Announcements
Presentation
Questions, Answers, and Discussion
Jill E. Blind, PharmD, CCRP Pharmacy Manager Nationwide Children's Hospital
Kara K. Berasi, PharmD, MS CEO Haystack Project
Blake Shay, PharmD, MS Pharmacy Manager BayCare Health System
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
CPEL Recertification Credit
This activity offers 1.0 point of CPEL recertification credit. Be sure to claim your CPEL certificate of participation when you process CE to track recertification hours earned. For assistance claiming a CPEL certificate of completion, contact elearning@ashp.org.
